by mroseboro | Aug 5, 2021 | Featured News |
FEATURED NEWS 2021 > August Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer Collaboration Leverages Kite’s Chimeric Antigen Receptors and Appia Bio’s Allogeneic Cell Technology Platform to Develop Off-the-Shelf...
by jrondon | May 11, 2021 | Featured News, News |
FEATURED NEWS 2021 > May Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board Proceeds will be used to progress stem cell derived CAR-engineered invariant natural killer T cells (CAR-iNKT) to the clinic in hematological...
Recent Comments